Design and synthesis of 3-pyrrol-3-yl-3H-isobenzofuran-1-ones as inhibitors of human cytosolic phospholipase A2alpha

J Enzyme Inhib Med Chem. 2008 Dec;23(6):946-57. doi: 10.1080/14756360701810249.

Abstract

A series of 3-pyrrol-3-yl-3H-isobenzofuran-1-ones was synthesized and assessed for the ability to inhibit cytosolic phospholipase A(2)alpha (cPLA(2)alpha). Several of these compounds were found to be active in both a cell based assay and an isolated enzyme assay. The most potent inhibitor was the thiazolidine-2,4-dione substituted derivative 35. With IC(50)-values of 0.7 muM and 7.3 muM in the cellular and isolated enzyme assay, respectively, it possesses similar inhibitory potency as the known cPLA(2)alpha inhibitor arachidonyltrifluoromethyl ketone (AACOCF(3)). Structure-activity relationship studies revealed that the evaluated isobenzofuran-1-ones seem to exert their cellular activities not only by a direct interaction with the enzyme but also by other as yet unknown mechanisms.

MeSH terms

  • Benzofurans / chemical synthesis*
  • Benzofurans / chemistry
  • Benzofurans / pharmacology*
  • Blood Platelets / drug effects
  • Blood Platelets / enzymology
  • Drug Design*
  • Enzyme Inhibitors / chemical synthesis*
  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / pharmacology*
  • Group IV Phospholipases A2 / antagonists & inhibitors*
  • Group IV Phospholipases A2 / metabolism
  • Humans
  • Molecular Structure
  • Pyrroles / chemistry*
  • Structure-Activity Relationship

Substances

  • Benzofurans
  • Enzyme Inhibitors
  • Pyrroles
  • Group IV Phospholipases A2
  • benzofuran